OMC Healthcare is dedicated in research, development and manufacturing of in vitro rapid diagnostic tests and molecular diagnostic products to contribute in early diagnosis and health with innovative technology. Through the development of in vitro diagnostics technology, OMC Healthcare has successfully commercialized products of outstanding quality to battle infectious and other diseases that pose a serious health threat across the globe. Since our inception in 2011, we have built a strong presence in the medical diagnosis industry though high-quality rapid diagnostics tests (RDT) for prompt and accurate diagnosis. OMC Healthcare strives to develop diagnostic tests in diverse fields and enhance the wellbeing and quality of life for people around the world.

We have built up our reputation successfully by carrying out various R & D projects based on next generation technology, experience, and human resources accumulated over the years.

Thank you for visiting OMCH!

OMC Healthcare is a dynamic Biotechnology company- develops and commercializes rapid diagnostic tests and molecular diagnostic detection kits, to empower labs to obtain reliable, timely, and actionable answers. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, biomedical research, agrigenomics and animal and food safety.
Since the establishment, our research has been continuously devoted to in vitro diagnostic business and has made us the leading manufacturer in the field of In-vitro diagnostics. Based on endless R&D, we have developed wide range of rapid and molecular tests for fertility, cardiac markers, infectious diseases, tumor markers, drugs of abuse to reach the needs of the global market desires. We continue to challenge ourselves to approach and meet the demands and need of our customers in various conditions of healthcare.
We operate on an ISO 9001, ISO 13485 certified and WHO GMP compliance facility under Full Quality Assurance Systems.

We develop, manufacture, and promote innovative in-vitro diagnostics in the field of rapid diagnostic tests and molecular diagnostic products.
Our dedication and effort in R&D have lead us in developing and launching new products every year and brought us a step closer to satisfying our customers’ demand. OMCH tries to meet the market demands for accurate and cost-effective in vitro diagnosis at a whole new level of technology and product development.

  • Launch innovative IVD products through progressive technology;
  • Maintain stringent quality control and strengthen relationship with customers and pursue a harmonious growth. We want to work, grow and succeed together with our customers.
  • Enhance sustainability of profits by reduce costs via product diversification, economies of scale, and production automation.
+ Our Company

OMC Healthcare is dedicated in research, development and manufacturing of in vitro rapid diagnostic tests and molecular diagnostic products to contribute in early diagnosis and health with innovative technology. Through the development of in vitro diagnostics technology, OMC Healthcare has successfully commercialized products of outstanding quality to battle infectious and other diseases that pose a serious health threat across the globe. Since our inception in 2011, we have built a strong presence in the medical diagnosis industry though high-quality rapid diagnostics tests (RDT) for prompt and accurate diagnosis. OMC Healthcare strives to develop diagnostic tests in diverse fields and enhance the wellbeing and quality of life for people around the world.

We have built up our reputation successfully by carrying out various R & D projects based on next generation technology, experience, and human resources accumulated over the years.

+ Our Message

Thank you for visiting OMCH!

OMC Healthcare is a dynamic Biotechnology company- develops and commercializes rapid diagnostic tests and molecular diagnostic detection kits, to empower labs to obtain reliable, timely, and actionable answers. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, biomedical research, agrigenomics and animal and food safety.
Since the establishment, our research has been continuously devoted to in vitro diagnostic business and has made us the leading manufacturer in the field of In-vitro diagnostics. Based on endless R&D, we have developed wide range of rapid and molecular tests for fertility, cardiac markers, infectious diseases, tumor markers, drugs of abuse to reach the needs of the global market desires. We continue to challenge ourselves to approach and meet the demands and need of our customers in various conditions of healthcare.
We operate on an ISO 9001, ISO 13485 certified and WHO GMP compliance facility under Full Quality Assurance Systems.

+ Vision

We develop, manufacture, and promote innovative in-vitro diagnostics in the field of rapid diagnostic tests and molecular diagnostic products.
Our dedication and effort in R&D have lead us in developing and launching new products every year and brought us a step closer to satisfying our customers’ demand. OMCH tries to meet the market demands for accurate and cost-effective in vitro diagnosis at a whole new level of technology and product development.

  • Launch innovative IVD products through progressive technology;
  • Maintain stringent quality control and strengthen relationship with customers and pursue a harmonious growth. We want to work, grow and succeed together with our customers.
  • Enhance sustainability of profits by reduce costs via product diversification, economies of scale, and production automation.
+ History